Clarify Medical, a Serra Capital III portfolio company, has received FDA clearance for its main technology - The Clarify Medical Phototherapy System, which is the core technology of its Clarify Home Light Therapy service. Clarify’s proprietary technology allows patients with chronic skin diseases to receive UVB phototherapy in their homes, linked to their physicians and to Clarify support services through their smartphones. The company plans to start offering the technology in November of 2017.

“This is a major milestone,” said James M. Sweeney, Clarify Medical’s CEO. “We look forward to offering Clarify Home Light Therapy to patients throughout the country, beginning in November. It offers an in-office therapy proven effective with skin diseases such as psoriasis, vitiligo, and eczema in a convenient form.”